Therapeutic Goods Amendment (Medicines Shortages and Other Measures) Bill 2026
UnknownSummary
This amendment to the Therapeutic Goods Act gives the Australian regulator new powers to manage shortages of essential medicines and make faster decisions about which drugs can be used in Australia. When a medicine becomes scarce or unavailable, the government can now act more quickly to approve alternatives or temporary solutions without going through the usual lengthy approval process. This matters because medicine shortages can leave patients without treatment for serious conditions, and the current system can be too slow to respond when supplies run dry — the new powers let authorities keep Australians supplied with the medications they need while still maintaining safety standards.
Bill Progress
Senate
First Reading
Second Reading
Committee of the Whole
Third Reading
House of Representatives
First Reading
Second Reading
Consideration in Detail
Third Reading
Royal Assent
Royal Assent